US FDA plans to open a manufacturing research lab near its White Oak headquarters in 2021 to facilitate evaluation of novel manufacturing technology.
Construction of a new manufacturing laboratory is expected to begin in fiscal year 2020 near the US Food and Drug Administration’s headquarters to study technology the agency wants industry to adopt.
Instructure improvement plans include “design and construction of a new [Center for Drug Evaluation and Research] laboratory near the White...
Create an account to read this article
Already a subscriber?
The CDER FY 2024 annual inspections report says the largest inspection increase was in China.
Companies that market drugs in Taiwan must submit electronic versions of their package inserts to Taiwan’s drug regulator by the year-end, lawyers say.
The Drug Regulatory Authority of Pakistan has adopted a new benchmark for good manufacturing practices, ensuring that the quality and safety of medicines produced in Pakistan meet international standards.
Generic drug industry representatives applauded the FDA decision to bring back key staff in the Office of Generic Drugs that were laid off earlier this year.
The Drug Regulatory Authority of Pakistan has adopted a new benchmark for good manufacturing practices, ensuring that the quality and safety of medicines produced in Pakistan meet international standards.
Generic drug industry representatives applauded the FDA decision to bring back key staff in the Office of Generic Drugs that were laid off earlier this year.
The White House is directing the Health and Human Services Department to replenish stockpiles of active pharmaceutical ingredients for “especially critical” medicines.
